Search

Alkem Laboratories

Sector: Healthcare | Industry: Drugs & Pharma
R 1,778.85 -31.85  | -1.76% -8.84% 28.00 21,296.92
NSE Price: Jun 18, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Jun 18, 15:59 1,778.85 -31.85 -1.76% 1,802.00 1,810.70 23,670 1,772.00 - 1,814.95
BSE Jun 18, 2019 1,781.20 -24.55 -1.36% 1,797.05 1,805.75 412 1,771.55 - 1,813.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
TTM Mar-18 Mar-17 Mar-16 Mar-15 Mar-14 Mar-13
Income StatementR Cr
Operating Revenue7,367.616,421.855,687.534,924.843,743.35 3,126.002,495.23
Other Income77.2895.95112.01239.71181.04 165.35167.17
Total Income7,444.896,517.805,799.545,164.553,924.39 3,291.352,662.40
Total Expenditure6,242.425,393.464,688.584,071.593,321.52 2,716.052,132.78
Operating Profit1,202.471,124.341,110.961,092.96602.87 575.30529.62
Interest54.6355.3345.1671.2481.11 93.0888.23
PBDT1,147.841,069.011,065.801,021.72521.76 482.22441.39
Depreciation193.18143.03101.1793.3170.94 52.2639.79
PBT & Exceptional Items954.66925.98964.63928.41450.82 429.96401.60
Exceptional Items0.00---- --
Profit before Tax954.66925.98964.63928.41450.82 429.96401.60
Provision for Tax181.02287.5659.96176.1859.23 -5.3617.97
Profit after Tax773.64638.42904.67752.23391.59 435.32383.63
Minority Interest-13.13-7.48-12.64-10.64- -0.19
Share of Associate0.00---- --
Consolidated Profit760.51630.94892.03741.59391.59 435.32383.82
 
LiabilitiesR Cr
Share Capital23.9123.9123.9123.9123.91 11.9611.96
Total Reserves5,415.434,838.874,443.343,668.032,978.72 2,573.012,165.35
Shareholder's Funds5,439.344,863.774,467.643,691.963,002.63 2,584.972,177.31
Minority Interest132.61121.55115.2395.0285.65 --
Long Term Borrowings231.30130.73181.56123.4633.43 232.25255.59
Other Non Current Liabilities214.72164.60113.4685.61163.59 91.67106.08
Current Liabilities2,190.222,383.311,689.691,537.602,005.98 1,402.581,731.80
Total Debt*-997.56659.46657.501,305.92 1,128.431,548.54
Total Liabilities8,208.197,663.966,567.585,533.655,291.28 4,311.474,270.78
 
AssetsR Cr
Net Block2,149.882,283.601,797.041,449.541,374.34 1,170.011,072.12
Non Current Investments95.74196.47259.44234.39419.73 338.24410.33
Other Non-Current Assets1,746.441,268.701,593.961,081.021,159.16 1,201.08632.11
Current Investments227.88247.80293.56274.1861.05 249.7767.31
Cash and Bank661.60576.78399.26780.90790.76 206.29995.45
Other Current Assets3,326.653,090.612,224.321,713.621,486.24 1,146.081,093.46
Net Current Assets2,025.911,531.881,227.451,231.10332.07 199.56424.42
Miscellaneous Exp. Not Written Off----- --
Total Assets8,208.197,663.966,567.585,533.655,291.28 4,311.474,270.78
 
Cash FlowR Cr
From Operations-276.18471.14725.83325.47 290.0178.05
From Investing Activities--367.37-285.93202.27-236.97 350.44-403.52
From Finance Activities-84.56-137.88-927.27-51.78 -599.94355.64
Net Inflow/Outflow--6.6347.330.8336.72 40.5130.17
 
Key Ratios
Adjusted EPS (Rs)63.6152.7874.6262.0332.76 36.4032.09
Adjusted Book Value (Rs)454.93406.76373.67308.82251.16 216.13182.05
Dividend per Share (Rs)-13.0015.0012.704.00 4.004.00
Cash Flow per Share (Rs)-23.1039.4160.7127.22 242.4865.26
Debt to Equity0.040.210.150.180.43 0.440.71
Current Ratio1.921.641.731.801.17 1.141.25
ROCE (%)-17.8621.3123.0913.26 14.0614.96
RONW (%)15.0213.6922.1822.4714.02 18.2819.19
Operating Margin (%)16.3217.5119.5322.1916.11 18.4021.23
Net Margin (%)10.399.8015.6014.579.98 13.2314.41
Revenue Growth (%)15.0312.9115.4931.5619.75 25.2823.79
Net Profit Growth (%)21.18-29.4320.2792.10-10.05 13.47-5.47
EPS Growth (%)20.54-29.2720.2989.38-10.01 13.42-5.59
Book Value Growth (%)-8.8521.0022.9616.16 18.7219.63
 
Market Cues
Close Price (Rs)1,778.851,988.352,204.901,356.45- --
High Price (Rs)2,268.002,469.002,227.951,588.90- --
Low Price (Rs)1,670.001,578.301,152.501,227.00- --
Market Cap (Rs Cr)21,296.9223,635.0426,384.0916,336.510.00 0.000.00
Price / Earnings28.0037.4629.5822.030.00 0.000.00
Price / Book Value3.924.865.914.420.00 0.000.00
Dividend Yield (%)0.730.660.680.93- --
TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
*Total Debt is long term borrowings plus short term borrowings plus current maturities of long term borrowings.
comments powered by Disqus
Essential checks
Altman Z-Score
7.29
Piotroski F-Score
3
Modified C-Score
5
3-Years Price to Earnings
28.00
3-Years Price to Book
3.92
Earnings Yield
EBIT / Enterprise value
4.70%
PEG
Price / Earnings to growth ratio
29.79
Related Stocks
  Current Price   Chng %
Abbott India R8,519.70 +0.09%
Bayer CropScience R3,341.20 -2.25%
Cadila Healthcare R233.95 -3.68%
Glaxosmithkline Pharma R1,252.85 -0.40%
Glenmark Pharma. R527.15 +1.25%
Ipca Laboratories R905.30 -0.48%
Pfizer R3,159.80 -0.84%
Sanofi India R5,419.55 -0.09%
Syngene International R318.95 -0.34%
Torrent Pharmaceuticals R1,511.55 +0.90%
As on Jun 18, 15:59